Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...

Scientists have made an important discovery about one of the most dangerous forms of ovarian cancer, offering new hope for ...

ANN ARBOR, Michigan — A new study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments. High-grade serous carcinoma, ...

Most uterine cancers have excellent five-year survival rates – up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 ...

Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and ...

Effect of chemotherapy treatment on immunotherapy efficacy in colorectal cancer (CRC) patients with high microsatellite instability (MSI-H) and/or tumor mutational burden (TMB-H). This is an ASCO ...

Explore new findings on ovarian cancer and how blocking focal adhesion kinase can enhance immune response in treatment.

Mapping the burden of uterine cancer in the EU from 1990-2021: Global and national disparities, age trends, and implications for public health.

Cells in our immune system are best known for providing security against external invaders such as bacteria and viruses.